Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

John C Stevenson

Consultant Physician and Reader, National Heart & Lung Institute, Imperial College London, UK

Contact Info

Email:
j.stevenson@imperial.ac.uk

Recent stories

  • Close up of a woman's hand holding hormone replacement therapy (HRT) pills

    Establishing the risk related to hormone replacement therapy and cardiovascular disease in womenSubscription

    10 JAN 2017

    Hormone replacement therapy (HRT) has a profound impact on the cardiovascular system in postmenopausal women, achieved through its effects on metabolic risk factors for coronary heart disease (CHD) and on arterial function. Observational studies have consistently shown an association between postmenopausal HRT use and a reduced incidence of CHD. However, the largest randomised trial initially reported no overall benefit on CHD risk. Subsequent analyses and follow-up of the study have demonst

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.